Zealand acquires a struggling diabetes med-tech in push into US market

Zealand Pharma is expanding again.

Four months after buying out Canada’s Encycle Therapeutics and their library of GI-drugging peptides, Zealand has agreed to purchase Valeritas, a struggling medical technology company focused on diabetes. It will cost them $23 million.